In line with the recent literature [20], patients admitted to our division presented with different comorbidities, including arterial hypertension, cardiovascular disease and diabetes, as the most frequent and were treated with ACE inhibitors, angiotensin receptor blockers, statins and anti-diabetic medications, as previously documented in other studies conducted among adults hospitalized for COVID-19 [21]. This evidence concerns the gene ACE and COVID-19.